Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Specialty Devices
Drug Delivery Devices
Return to: MDBR Home | Specialty Devices | Drug Delivery Devices

Drug Delivery Devices

Medtronic gets FDA nod for new lengths of IN.PACT Admiral drug-coated balloon By MDBR Staff Writer
Medtronic has secured approval from the US Food and Drug Administration (FDA) for 200mm and 250mm lengths of the IN.PACT Admiral drug-coated balloon (DCB) for the treatment of long superficial femoral artery (SFA) lesions in patients with peripheral artery disease (PAD).
Specialty Devices > Drug Delivery Devices > News
BD, Helmer Scientific to launch first fully integrated refrigerated automated dispensing solution Becton, Dickinson and Company (BD) and Helmer Scientific have collaborated to introduce an industry-first medical-grade refrigerated solution integrated with an automated dispensing system.
Specialty Devices > Drug Delivery Devices > News Medtronic starts US study of DES to treat bifurcation lesions in patients with CAD By MDBR Staff Writer
Medtronic has started the US clinical study for the evaluation of safety and efficacy of drug-eluting stents (DES) to treat bifurcation lesions in patients with coronary artery disease (CAD).
Specialty Devices > Drug Delivery Devices > News
See more Drug Delivery Devices news

Latest Drug Delivery Devices News and Insight

View all Drug Delivery Devices news or find news targeted to your interests
BD, Helmer Scientific to launch first fully integrated refrigerated automated dispensing solution
Becton, Dickinson and Company (BD) and Helmer Scientific have collaborated to introduce an industry-first medical-grade refrigerated solution integrated with an automated dispensing system.
Specialty Devices > Drug Delivery Devices > News
Medtronic starts US study of DES to treat bifurcation lesions in patients with CAD
By MDBR Staff Writer
Medtronic has started the US clinical study for the evaluation of safety and efficacy of drug-eluting stents (DES) to treat bifurcation lesions in patients with coronary artery disease (CAD).
Specialty Devices > Drug Delivery Devices > News
Meet SHL at BIO International Convention 2018
SHL Group, a world leader in device design and manufacturing, is proud to be participating in the 2018 BIO International Convention in Boston, Massachusetts from June 4-7. SHL will be at Booth #2525 to show its range of patient-friendly drug delivery solutions, which can accommodate any formulation for subcutaneous and intramuscular injection: low viscosity, high viscosity, high volume, unstable, and more. Representatives will also be on-site to introduce SHL’s turnkey solution, which leverages a full suite of in-house capabilities to take clients from device design to finished product distribution. Drawing over 16,000 participants from 5,000 companies last year, BIO International Convention is a premier biotech convention for industry partnering, education, and networking. SHL looks forward to connecting with top biotech and pharma companies and helping them meet their clinical and commercial needs. To learn more about our offering, visit at Booth #2525 at the Boston Convention & Exhibition Center. About SHL SHL is a world-leading solution provider in the design, development and manufacturing of advanced drug delivery devices such as auto injectors and pen injectors. With locations in Taiwan, Sweden and the US, our experienced engineers and designers develop product enhancements and breakthrough drug delivery solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities. With over 3,700 staff worldwide, our organization consists of several distinct group companies: SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products For additional information visit www.shl.group SHL Media Contact info@shl-group.com
Specialty Devices > Drug Delivery Devices > Press Releases
United Therapeutics to buy SteadyMed in $216m deal
By MDBR Staff Writer
United Therapeutics has signed an agreement to acquire specialty pharmaceutical firm SteadyMed in a deal worth $216m.
Specialty Devices > Drug Delivery Devices > News
Precision Therapeutics signs LOI to buy remaining Helomics shares
US-based Precision Therapeutics has signed a Letter of Intent (LOI) to acquire the remainder of the equity in Helomics.
Specialty Devices > Drug Delivery Devices > News
FDA approves Medtronic's drug-coated balloon to treat long SFA lesions
By MDBR Staff Writer
The US Food and Drug Administration (FDA) has approved Medtronic‘s In.Pact Admiral drug-coated balloon for the treatment of long superficial femoral artery lesions up to 360mm in patients with peripheral artery disease.
Specialty Devices > Drug Delivery Devices > News
SHL to Participate in Prefilled Syringe Seminar 2018 Tokyo
SHL Group is looking forward to exhibiting at the Prefilled Syringe Seminar 2018 Tokyo held by the Parenteral Drug Association (PDA) Japan Chapter from May 22-23.
Specialty Devices > Drug Delivery Devices > Press Releases
View all Drug Delivery Devices news or find news targeted to your interests